vimarsana.com

Page 22 - ஸ்டான்போர்ட் பல்கலைக்கழகம் பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Never Have I Ever S2: Paxton Important for Japanese Diaspora

When Netflix’s Never Have I Ever first premiered in 2020, the series was hailed as a groundbreaking coming-of-age series with a South Asian lead. Its lead characters are incredibly diverse. For starters, Devi Vishakumar and her immediate family members are Indian-American. Devi’s two best friends are Fabiola Torres, a queer Afro-Latinx character, and Eleanor Wong, a Chinese-American character. Devi also finds herself in a love triangle with two boys. One love interest is Ben Gross, a Jewish sophomore with whom she frequently verbally spars, and the other is Paxton Hall-Yoshida, a popular Japanese-American junior who is on the swim team. While season one gave Ben an entire episode to further explore his character, Paxton was left out to dry, much to the chagrin of fans of the character. Season two remedied this and gave Paxton a significant amount of material and character development that focused on a number of important issues related to the depiction and history of Japanese-

Yale researchers find gaps in clinical trial data sharing

By Mike Cummings July 30, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) Access to clinical-trial data helps doctors make informed prescribing decisions and promotes good science, but a new study co-authored by Yale researchers reveals that few pharmaceutical companies are fully transparent about the data behind the products they develop. The study also shows that large companies are far more transparent than smaller ones. The study, published in The BMJ Open (British Medical Journal), assessed the data-sharing practices of 42 pharmaceutical companies for clinical trials of 40 novel drugs and 22 biologics products, such as vaccines, derived from living organisms approved by the U.S. Food and Drug Administration in 2016 and 2017. The evaluation was performed using the Good Pharma Scorecard, a tool developed by researchers at Yale, Stanford, and Bioethics International which consists of transpare

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.